Transaction · 0001999371-26-010751

Hunter James Randolph Jr

Hunter James Randolph Jr, DIR, reported a transaction classified as grant at Tonix Pharmaceuticals Holding Corp. involving 22700.000000 shares for an estimated $0.00. Reported holdings after the transaction were 22700.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
TNXPTonix Pharmaceuticals Holding Corp.
Disclosed value$0Shares × reported price
Shares traded22.7k$0.00 per share
Holdings after22.7kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TNXP price since this filing

Daily closing prices, with the filing date and available return windows
TNXP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001999371-26-010751
Stock Option
Transaction date
May 12, 2026
Filed May 14, 2026, 09:46 PM · 2d delay
Shares
22,700 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
22,700 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Original filing · 0001999371-26-010751
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TNXP